Skip to main content
SpringerLink
Log in

CPAP Treatment in Resistant Hypertension

  • COMMENT
  • Published:
Current Sleep Medicine Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Javaheri S, Barbe F, Campos-Rodriguez F, Dempsey JA, Khayat R, Javaheri S, et al. Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol. 2017;69:841–58.

    Article  PubMed  PubMed Central  Google Scholar 

  2. https://www.who.int/news-room/fact-sheets/detail/hypertension. Last Access 26–08–2023.

  3. Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature based analysis. Lancet Respir Med. 2019;7:687–98.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Grassi G, Quarti-Trevano F, Mancia G. Obstructive sleep apnea, CPAP and arterial hypertension: a cardiologist’s view point. Arch Bronconeumol. 2022;58:461–2.

    Article  PubMed  Google Scholar 

  5. Alonso-Fernández A, CerdáMoncadas M, Álvarez Ruiz De Larrinaga A, Sánchez Barón A, CodinaMarcet M, et al. Impact of obstructive sleep apnea on gestational diabetes mellitus. Arch Bronconeumol. 2022;58:219–27.

    Article  PubMed  Google Scholar 

  6. Sánchez-de-la-Torre M, Campos-Rodriguez F, Barbé F. Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med. 2013;1:61–72.

    Article  PubMed  Google Scholar 

  7. Sapiña-Beltrán E, Gracia-Lavedan E, Torres G, Gaeta AM, Paredes J, Mayoral A, et al. Prevalence of obstructive sleep apnoea and its association with atherosclerotic plaques in a cohort of subjects with mild-moderate cardiovascular risk. Arch Bronconeumol. 2022;58:490–7.

    Article  PubMed  Google Scholar 

  8. Lloberes P, Silveira MG, Sampol J, Esquinas C, Espinel E, Ferrer R, et al. Is there an association between nocturia and nighttime hypertension in patients with moderate to severe sleep apnea? Arch Bronconeumol. 2022;58:369–71.

    Article  PubMed  Google Scholar 

  9. Narkiewicz K, Somers V. The sympathetic nervous system and obstructive sleep apnea implications for hypertension. J Hypert. 1997;15:1613–9.

    Article  CAS  Google Scholar 

  10. Fernández-Bello I, MonzónManzano E, García Río F, Justo Sanz R, Cubillos-Zapata C, Casitas R, et al. Procoagulant state of sleep apnea depends on systemic inflammation and endothelial damage. Arch Bronconeumol. 2022;58:117–212.

    Article  PubMed  Google Scholar 

  11. García-Río F, Alcázar-Navarrete B, Castillo-Villegas D, Cilloniz C, García-Ortega A, Leiro-Fernández V, et al. Biological biomarkers in respiratory diseases. Arch Bronconeumol. 2022;58:323–33.

    Article  PubMed  Google Scholar 

  12. Mediano O, González Mangado N, Montserrat JM, Alonso-Álvarez ML, Almendros I, Alonso-Fernández A, et al. Spanish sleep network. International consensus document on obstructive sleep apnea. Arch Bronconeumol. 2022;58:52–68.

    Article  PubMed  Google Scholar 

  13. Pengo M, Soranna D, Giontella A, Perger E, Mattaliano P, Schwarz EI, et al. Obstructive sleep apnoea treatment and blood pressure: which phenotypes predict a response? A systematic review and meta-analysis. Eur Resp J. 2020;50:1901945.

    Article  Google Scholar 

  14. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403–19.

    Article  CAS  PubMed  Google Scholar 

  15. Matanes F, Khan MB, Siddiqui M, Dudenbostel T, Calhoun D, Oparil S. An update on refractory hypertension. Curr Hypertens Rep. 2022;24:225–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Martinez-Garcia MA, Navarro-Soriano C, Torres G, Barbé F, Caballero C, Lloberes P, et al. Beyong resistant hypertension. Relationship between refractory hypertension and obstructive sleep apnea. Hypertension. 2018;72:618–24.

    Article  CAS  PubMed  Google Scholar 

  17. Martínez-García M-A, Capote F, Campos-Rodríguez F, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310:2407–15.

    Article  PubMed  Google Scholar 

  18. Labarca G, Schmidt A, Dreyse J, Jorquera J, Enos D, Torres G, et al. Efficacy of continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA) and resistant hypertension (RH): systematic review and meta-analysis. Sleep Med Rev. 2021;58:101446.

    Article  CAS  PubMed  Google Scholar 

  19. Campos-Rodriguez F, Navarro-Soriano C, Reyes-Nuñez N, Torres G, Caballero-Eraso C, Lloberes P, Diaz-Cambriles T, Somoza M, Masa JF, Gonzalez M, Mañas E, de la Peña M, Barbe F, Garcia-Rio F, Montserrat JM, Muriel A, Garcia-Ortega A, Selma MJ, Martinez-Garcia MA;  on behalf the Spanish Sleep Network. Good long‐term adherence to continuous positive airway pressure therapy in patients with resistant hypertension and sleep apnea. J Sleep Res 2019 Oct;28(5):e12805. https://doi.org/10.1111/jsr.12805

  20. Navarro C, Torres G, Barbé F, Sanchez de la Torre M, Mañas P, Lloberes P, et al. The HIPARCO-2 study: long-term effect of continuous positive airway pressure on blood pressure in patients with resistant hypertension: a multicenter prospective study. J Hypertens. 2021;39:302–9.

    Article  Google Scholar 

  21. Navarro C, Martinez-Garcia MA, Torres G, Barbé F, Sanchez de la Torre M, Caballero C, et al. Long-term effect of CPAP treatment on cardiovascular events in patients with resistant hypertension and sleep apnea. Data From the HIPARCO-2 Study. Arch Bronconeumol. 2021;57:165–71.

    Google Scholar 

  22. Navarro-Soriano C, Martinez-Garcia MA, Torres G, Barbé F, Caballero C, Lloberes P, et al. Effect of continuous positive airway pressure in patients with true refractory hypertension and sleep apnea: a post-hoc intention-to-treat analysis of the HIPARCO randomized clinical trial. J Hypertens. 2019;37:1269–75.

    Article  CAS  PubMed  Google Scholar 

  23. Navarro-Soriano C, Martinez-Garcia MA, Torres G, Barbé F, Caballero C, Lloberes P, et al. Factors associated with the changes from a resistant to a refractory phenotype in hypertensive patients: a Pragmatic Longitudinal Study. Hypertens Res. 2019. https://doi.org/10.1038/s41440-019-0285-8.

    Article  PubMed  Google Scholar 

  24. Baillieul S, Tamisier R, Eckert DJ, Pépin JL. Current knowledge and perspectives for pharmacological treatment in OSA. Arch Bronconeumol. 2022;58:681–4.

    Article  PubMed  Google Scholar 

  25. Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension the Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023. https://doi.org/10.1097/HJH.0000000000003480.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Masa JF, Benítez ID, Sánchez-Quiroga MÁ, Gomez de Terreros FJ, Corral J, Romero A, et al. Effectiveness of CPAP vs. Noninvasive ventilation based on disease severity in obesity hypoventilation syndrome and concomitant severe obstructive sleep apnea. Arch Bronconeumol. 2022;58:228–36.

    Article  PubMed  Google Scholar 

  27. Neborak JM, Nowalk NC, Mokhlesi B. The overlap of obesity-hypoventilation syndrome and obstructive sleep apnea: how to treat? Arch Bronconeumol. 2022;58:531–2.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servicio de Neumología, Hospital Universitario y Politécnico La Fe, Valencia, Spain

    Grace Oscullo, Jose Daniel Gomez-Olivas & Miguel Ángel Martínez-García

  2. CIBERES de Enfermedades Respiratorias, ISCIII, Madrid, Spain

    Miguel Ángel Martínez-García

  3. Pneumology Department, Hospital Universitario y Politécnico La Fe, Avenida Fernando Abril Martorell 2026, Valencia, Spain

    Miguel Ángel Martínez-García

Authors
  1. Grace Oscullo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jose Daniel Gomez-Olivas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miguel Ángel Martínez-García
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MAMG wrote the original draft and the other authors (GO, JDGO) contributed equally to review it.

Corresponding author

Correspondence to Miguel Ángel Martínez-García.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Human and Animal Rights and Informed Consent

Since this is a commentary not including data, an ethics committee consent is not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oscullo, G., Gomez-Olivas, J.D. & Martínez-García, M.Á. CPAP Treatment in Resistant Hypertension. Curr Sleep Medicine Rep (2024). https://doi.org/10.1007/s40675-024-00295-8

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40675-024-00295-8

Search

Navigation